Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Aug 6;107(9):djv204.
doi: 10.1093/jnci/djv204. Print 2015 Sep.

RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

Lavanniya K Palani Velu  1 , Colin W Steele  1 , Euan J Dickson  1 , C Ross Carter  1 , Colin J McKay  1 , Paul G Horgan  1 , Donald C McMillan  1 , Nigel B Jamieson  2
Affiliations
Comment

RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

Lavanniya K Palani Velu et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Goldstein D, Von Hoff D. Goldstein D, et al. J Natl Cancer Inst. 2015 Aug 6;107(9):djv206. doi: 10.1093/jnci/djv206. Print 2015 Sep. J Natl Cancer Inst. 2015. PMID: 26251330 Free PMC article. No abstract available.

Comment on

References

    1. Goldstein D, El-Maraghi RH, Hammel P, et al. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst. 2015;107 (2):dju413 doi:10.1093/jnci/dju413. - PubMed
    1. Jamieson NB, Denley SM, Logue J, et al. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2011;18 (8):2318–2328. - PubMed
    1. Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47 (17):2633–2641. - PubMed
    1. Dienstmann R, Rodon J, Barretina J, et al. Genomic medicine frontier in human solid tumors: prospects and challenges. J Clin Oncol. 2013;31 (15):1874–1884. - PubMed
    1. Denley SM, Jamieson NB, McCall P, et al. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17 (5):887–898. - PubMed

MeSH terms